For: | Basaranoglu M, Najjar SM, Demirbag AE, Senturk H. Significant cohort of non-alcoholic fatty liver disease with portal vein thrombosis in transplant waiting list. World J Hepatol 2016; 8(7): 376-384 [PMID: 26981175 DOI: 10.4254/wjh.v8.i7.376] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v8/i7/376.htm |
Number | Citing Articles |
1 |
Hang Gong, Huang Zhong, Hui-Mei Xu, Xiong-Chang Liu, Liang-Ping Li, De-Kui Zhang. Insight into increased risk of portal vein thrombosis in nonalcoholic fatty liver disease. European Journal of Internal Medicine 2023; 114: 23 doi: 10.1016/j.ejim.2023.06.011
|
2 |
Jingjing Cai, Xiao-Jing Zhang, Yan-Xiao Ji, Peng Zhang, Zhi-Gang She, Hongliang Li. Nonalcoholic Fatty Liver Disease Pandemic Fuels the Upsurge in Cardiovascular Diseases. Circulation Research 2020; 126(5): 679 doi: 10.1161/CIRCRESAHA.119.316337
|
3 |
Metin Basaranoglu. Increased prevalence of portal vein thrombosis in patients with nonalcoholic steatohepatitis-cirrhosis due to increased proinflammatory cytokines releasing from abdominal adipose tissue. European Journal of Gastroenterology & Hepatology 2020; 32(3): 458 doi: 10.1097/MEG.0000000000001564
|